PATENT CLAIM ANALYSIS

Application Number: 16056314
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["435", "235100"]

Abstract:
Replicon virus-like particles can be used as flavivirus vaccines.

Claim (Index 11):
A method of making the particle of  claim 1 , comprising transforming a host cell with said replicon, wherein said replicon does not express a gene product essential for making an infectious virus particle, wherein said host cell expresses said gene product essential for making an infectious gene particle, and isolating particles produced by said host cell.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 96.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11622233', '13561002', '12942632', '10656721', '12394822']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6484337096066888
- 35 USC 102 Novelty (BERT): 0.5495143604993433
- Combined Prediction Score: 0.6385417746959543
- Mean Citation Score: 338.005422
- Max Citation Score: 435.5754
- Similarity Product: 307.01969021025894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test